0001415889-22-000933.txt : 20220201 0001415889-22-000933.hdr.sgml : 20220201 20220201200540 ACCESSION NUMBER: 0001415889-22-000933 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220128 FILED AS OF DATE: 20220201 DATE AS OF CHANGE: 20220201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rabinowitz Matthew CENTRAL INDEX KEY: 0001646382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 22581013 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-02012022_080223.xml X0306 4 2022-01-28 0001604821 Natera, Inc. NTRA 0001646382 Rabinowitz Matthew C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 true true false false EXECUTIVE CHAIRMAN Stock Option (right to buy) 65.47 2022-01-28 4 A 0 110000 0 A 2032-01-27 Common Stock 110000 110000 D Stock Option (right to buy) 65.47 2022-01-28 4 A 0 110000 0 A 2032-01-27 Common Stock 110000 110000 D The option shares vest over four years. 25% of the option shares vest and become exercisable on January 20, 2023 and the remaining shares vest in thirty-six (36) equal monthly installments thereafter. The option shares shall vest when the Issuer has achieved a specified annual revenue. /s/ Tami Chen, Attorney-in-Fact 2022-02-01